Seeking Alpha
  • John Motyka
    1tallrn: Await your MAKO efficacy & post-op assessment...jdm
    11/14/12
    Reply (10)
    • TruffelPig: This with the MAKO secondary announced after a 9% drop yesterday bugs me. Leakage......
      11/14/12
    • John Motyka: Truffel: I don't know. 1tallrn actually in post operative clinical setting. She remains silent...jdm
      11/24/12
    • TruffelPig: Let us hope $MAKO makes a strong come back in 2013 - I am very long. Might sell some puts/calls to make up for some losses.
      11/24/12
    • John Motyka: Truffel:MAKO has been good to me. Still holding 25% of original postion.Ave. shr price =$11 CEO running Sales after firing CSO 4months ago!
      11/25/12
    • TruffelPig: Since then it has markedly improved. Needs one more good quarter :)
      11/25/12
    • John Motyka: Truffel: I am doubtful we will see $40 again unless shorts get squeezed really hard...jdm
      11/26/12
    • TruffelPig: I do not need to see 40 to have a very nice position. We might see 40 in 2 years or so. Depends on the business transition ongoing.
      11/26/12
    • John Motyka: Truffel: We should live that long. Mayan calander running out...jdm (lol)
      11/27/12
    • TruffelPig: The Mayan's didn't make it I fear.
      11/28/12
    • John Motyka: Truffel: We shall see...jdm
      11/29/12